Clinical trial
A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine…
NCT00150644 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00150644 |
|---|---|
| Title | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy |
| Official title | A Phase 2, 12-Week, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effects of J867 on Uterine Artery Blood Flow and the Morphology of the Endometrium, Myometrium, and Uterine Leiomyomata in Subjects With Uterine Leiomyomata Scheduled for Hysterectomy. |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Uterine Fibroids, Leiomyoma |
| Intervention type | Drug |
| Interventions | Asoprisnil, Placebo |
| Enrollment | 33 |
| Start date | Jul 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 8, 2005 |
| Last update posted | May 29, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: